Dentsply Sirona XRAY
$8.29 −$0.20 (-2.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.34 +0.60%
Open$8.45
Prev close$8.49
Day range$8.24 – $8.74
Volume4.88M
Market cap$1.64B
P/E (TTM)–
Dividend yield1.93%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$836.00M-7.5% YoY
Operating profit$37.00M-19.6% YoY
Net profit-$3.00M+99.3% YoY
Diluted EPS-$0.01+99.5% YoY
Free cash flow$0.00-100.0% YoY
Operating cash flow$32.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin50.5%
Operating margin4.9%
Net margin-3.4%
Return on equity-8.5%
Return on assets-2.2%
Return on invested capital-1.7%
Current ratio1.63
Liabilities / assets73.9%
Cash & investments$195.00M
Total debt$2.29B
Net cash (debt)-$2.09B
Free cash flow / sales2.9%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $836.00M | $898.00M | $880.00M | $3.68B | $961.00M |
| Total Operating Revenue | $836.00M | $898.00M | $880.00M | $3.68B | $961.00M |
| Cost of Revenue | $393.00M | $405.00M | $453.00M | $1.84B | $518.00M |
| Gross Profit | $443.00M | $493.00M | $427.00M | $1.84B | $443.00M |
| Operating Expense | $406.00M | $410.00M | $397.00M | $1.59B | $418.00M |
| Selling and Admin Expenses | $364.00M | $365.00M | $353.00M | $1.44B | $378.00M |
| -General & Admin Expense | $364.00M | $365.00M | $353.00M | – | – |
| Research & Development | $42.00M | $45.00M | $44.00M | $150.00M | $40.00M |
| Operating Profit | $37.00M | $83.00M | $30.00M | $252.00M | $25.00M |
| Net Non-Operating Interest Income (Expense) | -$25.00M | -$22.00M | -$24.00M | -$88.00M | -$22.00M |
| Non-Operating Interest Expense | $25.00M | $22.00M | $24.00M | $88.00M | $22.00M |
| Other Income (Expense) | $14.00M | $11.00M | -$48.00M | -$650.00M | -$150.00M |
| Gain on Sale of Security | $15.00M | $13.00M | $13.00M | $32.00M | $19.00M |
| Special Income (Charges) | -$1.00M | -$2.00M | -$67.00M | -$674.00M | -$159.00M |
| -Less:Restructuring and Mergern & Acquisition | -$2.00M | $2.00M | $67.00M | $24.00M | $6.00M |
| -Less:Impairment of Capital Assets | $3.00M | $0.00 | – | $650.00M | $153.00M |
| Pretax Profit | $26.00M | $72.00M | -$42.00M | -$486.00M | -$147.00M |
| Tax | $29.00M | $36.00M | -$32.00M | $112.00M | -$2.00M |
| Net Profit | -$3.00M | $36.00M | -$10.00M | -$598.00M | -$145.00M |
| Profit from Continuing Operations | -$3.00M | $36.00M | -$10.00M | -$598.00M | -$145.00M |
| Minority Interests | -$1.00M | -$1.00M | $0.00 | $0.00 | $1.00M |
| Net Income to Parent Company | -$2.00M | $37.00M | -$10.00M | -$598.00M | -$146.00M |
| Net Income to Common Stockholders | -$2.00M | $37.00M | -$10.00M | -$598.00M | -$146.00M |
| Basic EPS | -$0.01 | $0.18 | -$0.05 | -$3.00 | -$0.74 |
| Diluted EPS | -$0.01 | $0.18 | -$0.05 | -$3.00 | -$0.74 |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.64 | $0.16 |
| Other Non-Operating Income (Expenses) | – | – | $6.00M | -$8.00M | -$10.00M |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $5.19B | $5.20B | $5.23B | $5.43B | $5.43B |
| Total Current Assets | $1.98B | $1.93B | $1.85B | $2.02B | $2.02B |
| Cash and Cash Equivalents & Short-Term Investments | $195.00M | $239.00M | $190.00M | $326.00M | $326.00M |
| -Cash and Cash Equivalents | $195.00M | $239.00M | $190.00M | $326.00M | $326.00M |
| Receivables | $605.00M | $620.00M | $622.00M | $737.00M | $737.00M |
| -Accounts Receivable | $605.00M | $620.00M | $622.00M | $688.00M | $688.00M |
| Inventory | $707.00M | $665.00M | $659.00M | $642.00M | $642.00M |
| Other Current Assets | $471.00M | $404.00M | $374.00M | $150.00M | $150.00M |
| Total Non-Current Assets | $3.21B | $3.28B | $3.38B | $3.41B | $3.41B |
| Net PPE | $971.00M | $974.00M | $997.00M | $1.00B | $1.00B |
| -Gross PPE | $971.00M | $974.00M | $997.00M | $2.57B | $2.57B |
| Goodwill and Other Intangible Assets | $1.95B | $2.01B | $2.07B | $2.12B | $2.12B |
| -Goodwill | $1.14B | $1.14B | $1.14B | $1.15B | $1.15B |
| -Other Intangible Assets | $815.00M | $870.00M | $924.00M | $974.00M | $974.00M |
| Other Non-Current Assets | $290.00M | $294.00M | $321.00M | $284.00M | $284.00M |
| Total Liabilities | $3.84B | $3.85B | $3.91B | $4.09B | $4.09B |
| Total Current Liabilities | $1.22B | $1.19B | $1.21B | $1.34B | $1.34B |
| Payables | $296.00M | $293.00M | $289.00M | $330.00M | $330.00M |
| -Accounts Payable | $238.00M | $260.00M | $259.00M | $300.00M | $300.00M |
| -Total Tax Payable | $58.00M | $33.00M | $30.00M | $30.00M | $30.00M |
| Current Accrued Expenses | $706.00M | $664.00M | $688.00M | $260.00M | $260.00M |
| Short-Term Debt and Capital Lease Obligation | $215.00M | $228.00M | $230.00M | $360.00M | $360.00M |
| -Current Debt | $215.00M | $228.00M | $230.00M | $313.00M | $313.00M |
| Total Non-Current Liabilities | $2.62B | $2.67B | $2.70B | $2.75B | $2.75B |
| Long Term Debt and Capital Lease Obligation | $2.07B | $2.08B | $2.10B | $2.11B | $2.11B |
| -Long Term Debt | $1.99B | $2.00B | $2.01B | $2.02B | $2.02B |
| -Long Term Capital Lease Obligation | $87.00M | $88.00M | $95.00M | $93.00M | $93.00M |
| Non-Current Deferred Liabilities | $74.00M | $79.00M | $84.00M | $94.00M | $94.00M |
| Other Non-Current Liabilities | $473.00M | $505.00M | $518.00M | $544.00M | $544.00M |
| Total Equity | $1.35B | $1.35B | $1.32B | $1.34B | $1.34B |
| Stockholders' Equity | $1.36B | $1.35B | $1.32B | $1.34B | $1.34B |
| Capital Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -Common Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $6.62B | $6.62B | $6.62B | $6.64B | $6.64B |
| Retained Earnings | -$1.54B | -$1.54B | -$1.57B | -$1.56B | -$1.56B |
| Less: Treasury Stock | -$3.08B | -$3.08B | -$3.07B | -$3.11B | -$3.11B |
| Gains/Losses Not Affecting Retained Earnings | -$647.00M | -$656.00M | -$655.00M | -$639.00M | -$639.00M |
| Minority Interests | -$1.00M | $0.00 | $1.00M | $1.00M | $1.00M |
| -Taxes Receivable | – | – | – | $49.00M | $49.00M |
| Prepaid Assets | – | – | – | $168.00M | $168.00M |
| -Accumulated Depreciation | – | – | – | -$1.57B | -$1.57B |
| -Current Capital Lease Obligation | – | – | – | $47.00M | $47.00M |
| Current Provisions | – | – | – | $118.00M | $118.00M |
| Current Deferred Liabilities | – | – | – | $74.00M | $74.00M |
| Other Current Liabilities | – | – | – | $30.00M | $30.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $32.00M | $99.00M | $40.00M | $235.00M | $101.00M |
| Net cash flow from continuing operations | $32.00M | $99.00M | $40.00M | $235.00M | $101.00M |
| Net Income from Continuing Operations | -$3.00M | $36.00M | -$10.00M | -$598.00M | -$145.00M |
| Gain/Loss from Continuing Operations | -$1.00M | $0.00 | -$6.00M | – | – |
| Depreciation & Depletion & Amortization | $82.00M | $85.00M | $79.00M | $352.00M | $93.00M |
| Deferred Tax | -$8.00M | $18.00M | -$60.00M | $30.00M | -$14.00M |
| Other Non-Cash Items | $16.00M | $2.00M | -$15.00M | -$10.00M | -$23.00M |
| Change in Working Capital | -$65.00M | -$51.00M | $44.00M | -$222.00M | $29.00M |
| -Change in Receivables | $11.00M | -$4.00M | $60.00M | -$91.00M | -$35.00M |
| -Change in Inventory | -$46.00M | -$9.00M | -$23.00M | -$17.00M | $44.00M |
| -Change in Prepaid Assets | $6.00M | -$30.00M | $19.00M | -$7.00M | $3.00M |
| -Change in Payables and Accrued Expense | -$60.00M | -$4.00M | -$18.00M | -$63.00M | $12.00M |
| -Change in Other Current Assets | $0.00 | -$3.00M | $1.00M | -$7.00M | -$7.00M |
| -Change in Other Current Liabilities | -$2.00M | $2.00M | -$2.00M | -$5.00M | -$1.00M |
| -Change In Other Working Capital | $26.00M | -$3.00M | $7.00M | -$32.00M | $13.00M |
| Net cash flow from investing | -$43.00M | -$39.00M | -$53.00M | -$132.00M | -$45.00M |
| Net Cash Flow from Continuing Investing Activities | -$43.00M | -$39.00M | -$53.00M | -$132.00M | -$45.00M |
| Capital Expenditure | -$32.00M | -$44.00M | -$52.00M | -$131.00M | -$41.00M |
| Net PPE Purchase and Sale | -$1.00M | – | – | – | – |
| Net Investment Purchase and Sale | -$9.00M | -$1.00M | -$7.00M | -$4.00M | -$5.00M |
| Net Other Investing Changes | -$1.00M | $1.00M | $6.00M | $3.00M | $1.00M |
| Financing Cash Flow | -$28.00M | -$11.00M | -$119.00M | -$80.00M | -$99.00M |
| Net Cash Flow from Continuing Financing Activities | -$28.00M | -$11.00M | -$119.00M | -$80.00M | -$99.00M |
| Net Issuance Payments Of Debt | -$14.00M | $1.00M | -$82.00M | $70.00M | -$62.00M |
| Net Common Stock Issuance | -$13.00M | – | – | $0.00 | $0.00 |
| Cash Dividends Paid | $0.00 | $0.00 | -$32.00M | -$128.00M | -$32.00M |
| Net Other Financing Charges | -$1.00M | $0.00 | -$5.00M | -$22.00M | -$5.00M |
| Ending Cash Balance | $195.00M | $239.00M | $190.00M | $326.00M | $326.00M |
| Net Change in Cash | -$39.00M | $49.00M | -$132.00M | $23.00M | -$43.00M |
| Beginning Cash Balance | $239.00M | $190.00M | $326.00M | $272.00M | $363.00M |
| Effect of Exchange Rate Changes | -$5.00M | $0.00 | -$4.00M | $31.00M | $6.00M |
| Free Cash Flow | $0.00 | $55.00M | -$12.00M | $104.00M | $60.00M |
| Net Business Purchase and Sale | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on XRAY.
Sign in to join the discussion.